Select Page

Alicia Henn

Alicia Henn has been the Chief Scientific Officer of BioSpherix, Ltd since 2013. Previously, she was a researcher at the Center for Biodefense Immune Modeling in Rochester, NY. Alicia obtained her PhD in molecular pharmacology and cancer therapeutics from Roswell Park Cancer Institute in Buffalo, NY and her MBA from the Simon School at University of Rochester in Rochester, NY.

Biocontainment Cells Need Technician Protection

Biocontainment: Cells Need Technician Protection “I’ve been handling cells this way for years and I’VE never gotten sick.” How many times have you heard that, and doubted it? Continue reading to learn why biosafety and biocontainment have...

read more

Cytocentric Visionaries Tim Downing p3

Cytocentric Visionaries: Tim Downing, PhD Part Three: How Does the Question You Are Asking Change, in the Physiological Context, if You Are Not Working In Vivo? This post contains excerpts from an interview that Dr. Alicia Henn, Chief...

read more

Cytocentric Visionaries Tim Downing p2

Cytocentric Visionaries: Tim Downing, PhD Part Two: Physiologic Simulation: You Can Never Step in the Same River Twice This post contains excerpts from an interview that Dr. Alicia Henn, Chief Scientific Officer of BioSpherix, conducted with...

read more

Cytocentric Visionaries Tim Downing p1

Cytocentric Visionaries: Tim Downing, PhD Part One: Understanding the Effect of the In Vitro Microenvironment on the Epigenomics of Cell Reprogramming This post is part of a three-part series from an interview that Dr. Alicia Henn, Chief...

read more

Cytocentric Visionaries Roger Ronn p5

Cytocentric Visionaries: Roger Rönn Part Five: Unbroken Optimized Conditions for Hematopoietic Stem Cells. This is a five-part series of blog posts containing excerpts from an interview that Dr. Alicia Henn, Chief Scientific Officer of...

read more

Cytocentric Visionaries Roger Ronn p4

Cytocentric Visionaries: Roger Rönn Part Four: Physiologic Simulation for Hematopoietic Stem Cells This is a five-part series of blog posts containing excerpts from an interview that Dr. Alicia Henn, Chief Scientific Officer of BioSpherix,...

read more